167 related articles for article (PubMed ID: 22739774)
1. Reverse engineering for new oral anticoagulants: non-specific reversal agents and the anticoagulant activity of dabigatran and rivaroxaban.
Levi M
Thromb Haemost; 2012 Aug; 108(2):201-2. PubMed ID: 22739774
[No Abstract] [Full Text] [Related]
2. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.
Marlu R; Hodaj E; Paris A; Albaladejo P; Cracowski JL; Pernod G
Thromb Haemost; 2012 Aug; 108(2):217-24. PubMed ID: 22627883
[TBL] [Abstract][Full Text] [Related]
3. New oral anticoagulant in atrial fibrillation: are they comparable?
Kalodiki E; Lewis B; Fareed J
Int Angiol; 2012 Aug; 31(4):307-9. PubMed ID: 22801395
[No Abstract] [Full Text] [Related]
4. [New oral anticoagulants in the treatment of venous thromboembolic disease].
Calvo Romero JM; Lima Rodríguez EM
Semergen; 2013 Apr; 39(3):146-9. PubMed ID: 23540987
[TBL] [Abstract][Full Text] [Related]
5. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
Páramo JA
Med Clin (Barc); 2013 Oct; 141(8):346-8. PubMed ID: 23831406
[No Abstract] [Full Text] [Related]
6. A new era of anticoagulation.
Hainaut PH
Acta Clin Belg; 2012; 67(6):394-8. PubMed ID: 23340143
[No Abstract] [Full Text] [Related]
7. New oral anticoagulants in the management of venous thromboembolism: a major advance?
Sciascia S; Hunt BJ
Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):487-8. PubMed ID: 25150440
[No Abstract] [Full Text] [Related]
8. ["Xa-tra-xa": opportunities and open questions about new anticoagulants].
Beer JH
Praxis (Bern 1994); 2011 Aug; 100(16):947. PubMed ID: 21910293
[No Abstract] [Full Text] [Related]
9. Newer anticoagulants for the prevention of venous thromboembolism.
Jaggia A
Natl Med J India; 2012; 25(1):22-5. PubMed ID: 22680317
[No Abstract] [Full Text] [Related]
10. [New anticoagulants].
Godier A; Martin AC; Lakhdari M; Samama CM
Rev Prat; 2011 Nov; 61(9):1239-43. PubMed ID: 22308807
[TBL] [Abstract][Full Text] [Related]
11. Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: the need to manage the introduction of new drugs.
Troncoso A; Diogène E
Eur J Clin Pharmacol; 2014 Feb; 70(2):249-50. PubMed ID: 24132558
[No Abstract] [Full Text] [Related]
12. Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.
Skjøth F; Larsen TB; Rasmussen LH
Thromb Haemost; 2012 Sep; 108(3):405-6. PubMed ID: 22782445
[No Abstract] [Full Text] [Related]
13. Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?
Harenberg J; Marx S; Wehling M
Thromb Haemost; 2012 Sep; 108(3):407-9. PubMed ID: 22837027
[No Abstract] [Full Text] [Related]
14. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
15. Should the newer oral anticoagulants be withheld from patients with valvular AF?
Dalen JE
Chest; 2013 Aug; 144(2):369-370. PubMed ID: 23918100
[No Abstract] [Full Text] [Related]
16. New options in anticoagulation for atrial fibrillation.
del Zoppo GJ; Eliasziw M
N Engl J Med; 2011 Sep; 365(10):952-3. PubMed ID: 21830960
[No Abstract] [Full Text] [Related]
17. New oral anticoagulants for the treatment of venous thromboembolism.
Agnelli G; Becattini C; Franco L
Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
[TBL] [Abstract][Full Text] [Related]
18. [Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants].
Yasaka M; Okada Y
Rinsho Shinkeigaku; 2012; 52(11):1113-6. PubMed ID: 23196533
[TBL] [Abstract][Full Text] [Related]
19. Switching between oral anticoagulants.
Strasser KM; Qasem A; Madhusudhana S
Hosp Pract (1995); 2014 Aug; 42(3):68-74. PubMed ID: 25255408
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Bauer KA
Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
